

Ozempic and similar weight loss drugs may lower risk of 42 health conditions
March 19, 2025
Ziyad Al-Aly - Today, GLP-1 drugs, including Wegovy, Mounjaro and Zepbound, have become household names and key tools in the fight against obesity: 1 in 8 American adults say they have used a GLP-1 drug, and forecasts show that by 2030, 1...
Klicken Sie hier, um weiterzulesen
Klicken Sie hier, um weiterzulesen